Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Massimiliano Fabbiani

Docenti di ruolo di IIa fascia

University of Siena

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Articles (20)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Collaborators (14)

Chiara Catelli

Ricercatori a tempo determinato

University of Siena

ITALY

View details

Giuseppe LAPADULA

Docenti di ruolo di IIa fascia

University of Milano-Bicocca

ITALY

View details

Maria Vittoria Cossu

ASST Fatebenefratelli Sacco

ITALY

View details

GIULIA CARLA MARCHETTI

University of Milan

ITALY

View details

MARGHERITA SAMBO

University of Siena

ITALY

View details

Tommaso Clemente

Ospedale San Raffaele

ITALY

View details

Luca Luzzi

Docenti di ruolo di IIa fascia

University of Siena

ITALY

View details

Vincenzo Spagnuolo

Vita-Salute San Raffaele University

ITALY

View details

Maria Mazzitelli

Agostino Gemelli University Polyclinic

ITALY

View details

Donata Medaglini

Docenti di ruolo di Ia fascia

University of Siena

ITALY

View details

ANDREA COSTANTINI

Assistant Professor of Clinical Immunology

Università Politecnica delle Marche

ITALY

View details

spinello antinori

Full Professor of Infectious Diseases

University of Milan

ITALY

View details

Alessandra Bandera

Associate Professor

University of Milan

ITALY

View details

Pietro Enea Lazzerini

University of Siena

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Massimiliano Fabbiani

Research Interests

Explore related searches

Articles (20)

Risk of Developing Low-Level Viral Rebound Among People With HIV Receiving 2- or 3-Drug Regimens: A Case-Control Study Nested in the ICONA Cohort

Did the COVID-19 pandemic shift the landscape of late HIV diagnosis?

Proportion of newly diagnosed persons with HIV with HIV-RNA greater than/equal to 500 000 copies/mL in 2018–2023 in Italy: data from the ICONA Foundation Cohort Study

‘Leaving no stones unturned’: up to 10 years results on the effectiveness, tolerability and metabolic safety of dolutegravir+lamivudine (DTG+3TC) as a switch regimen in the ODOACRE cohort

Treatment of post-lung transplantation pneumonia with cefiderocol: a case series and insights from the literature

Changes in cardiovascular and metabolic risk scores after switching to DOR/3TC/TDF, DTG/3TC or BIC/FTC/TAF: results from a multicenter Italian cohort

Durability of Long‐Acting Cabotegravir + Rilpivirine in Virologically Suppressed Adults Living With HIV: A Multicenter Observational Cohort in Tuscany (LAHIV)

Durability of lenacapavir in viremic heavily treatment-experienced people with HIV: real-world data from the PRESTIGIO Registry

Use of Tobacco and Alternative Nicotine Products Among People with HIV: A Cross-Sectional Multicenter Survey

Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO Registry

Urinary tract infections caused by Gram-negative bacteria in elderly hospitalized patients: Epidemiology, clinical features and outcomes in the era of antimicrobial resistance

Effectiveness and predictors of treatment discontinuation of long-acting cabotegravir/rilpivirine in virologically suppressed people with HIV: real-life data from the Icona Cohort

Long-term durability of dolutegravir plus darunavir/cobicistat dual regimen in highly antiretroviral-experienced people with HIV (DoDaco study)

Antigen-agnostic identification of poxvirus broadly neutralizing antibodies targeting OPG153

Booster dose reshapes SARS-CoV-2 RBD-specific B cell immunity in people living with HIV

Predictors for choosing doravirine‐based versus INSTI‐based regimen in ART‐naïve and ART‐experienced people with HIV in real‐world setting: Data from the Icona cohort

All-Cause Mortality in People With Four-Class Drug-Resistant HIV: A Matched Cohort Analysis With Data From the PRESTIGIO Registry

Effectiveness of first-line lamivudine/dolutegravir antiretroviral therapy in persons with HIV: real-life data from the ICONA Foundation cohort

Evolution of Self-reported Neuropsychiatric Symptoms After Switching from Dolutegravir/Abacavir/Lamivudine to Bictegravir/Emtricitabine/Tenofovir Alafenamide: Results from the Randomized DOBINeuro Trial

Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster doses

Collaborators (14)

Chiara Catelli

Giuseppe LAPADULA

Maria Vittoria Cossu

GIULIA CARLA MARCHETTI

MARGHERITA SAMBO

Tommaso Clemente

Luca Luzzi

Vincenzo Spagnuolo

Maria Mazzitelli

Donata Medaglini

ANDREA COSTANTINI

spinello antinori

Alessandra Bandera

Pietro Enea Lazzerini

Make your next move.